Propel Bio Management, LLC

报告期 2026-03-31 · CIK 0001969764

持仓数

前50大市值合计

$158.7M

报告期

2026-03-31

当前持仓调仓

组合演变前 6 大持仓 + 其他逐季市值($B) · 点图或下方季度看该季调仓

看某季调仓:

26Q1 25Q4 25Q3 25Q2 25Q1 24Q4 24Q3 24Q2 24Q1 23Q4

24Q1 调仓2023-12-31 → 2024-03-31 · 共 20 项建仓 4增持 5减持 1清仓 10

方向

标的

Δ市值

现股数(环比)

增持

HIGH SIMPLIFY ENHANCED INCOME

+$25.0M

1,492,581 +1142%

增持

— APPLIED THERAPEUTICS INC

+$23.6M

6,111,906 +14%

清仓

PAGP PLAINS GP HOLDINGS LP-CL

-$21.9M

0 -100%

调仓由相邻两季 13F 持仓相减推导(非逐笔成交);方向按股数增减,Δ市值受股价波动影响、符号可与方向相反;13F 申报滞后最长 45 天。

ACHV ACHIEVE LIFE SCIENCES INC

增持

— AKERO THERAPEUTICS INC

+$5.9M

327,752 +228%

清仓

CRNX CRINETICS PHARMACEUTICALS IN

-$5.9M

0 -100%

增持

PHAT PHATHOM PHARMACEUTICALS INC

+$5.2M

869,927 +96%

减持

— FIDELITY INV MMTRSY 1 680

-$4.6M

211,541 -96%

增持

MDGL MADRIGAL PHARMACEUTICALS INC

+$4.5M

43,032 +43%

清仓

BSV VANGUARD SHORT-TERM BOND

-$2.1M

0 -100%

清仓

— ISHARES IBONDS DEC 2024 T

-$2.1M

0 -100%

建仓

SNDX SYNDAX PHARMACEUTICALS INC

+$2.0M

83,259

清仓

SPSB SPDR PORT SHRT TRM CORP B

-$1.4M

0 -100%

清仓

— EIGER BIOPHARMACEUTICALS INC

-$985.9K

0 -100%

建仓

TRVI TREVI THERAPEUTICS INC

+$897.0K

260,000

建仓

— EIGER BIOPHARMACEUTICALS INC

+$731.9K

146,381

清仓

SLQD ISHARES 0-5 YR INV GRD CO

-$597.7K

0 -100%

清仓

FLRN SPDR BLOOMBERG INVESTMENT

-$283.5K

0 -100%

清仓

HRTX HERON THERAPEUTICS INC

-$177.1K

0 -100%

清仓

AGIO AGIOS PHARMACEUTICALS INC

-$129.0K

0 -100%